| Line Item | 2022-04-30 | Y/Y |
|---|---|---|
| Revenue | $12.7M | — |
| R&D Expense | $70.2M | +70.0% |
| SG&A Expense | $26.4M | +59.0% |
| Operating Income | -$96.6M | -66.8% |
| Pre-tax Income | -$82.3M | -78.1% |
| Income Tax | $0 | — |
| Net Income | -$82.3M | -78.1% |
| EPS (Basic) | -$3.36 | -38.8% |
| EPS (Diluted) | -$3.36 |
| Line Item | 2022-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $30.7M | -39.3% |
| Current Assets | $193.6M | -26.7% |
| Total Assets | $203.9M | -25.0% |
| Current Liabilities | $11.6M | +18.4% |
| Stockholders' Equity | $185.1M | -28.0% |
| Line Item | 2022-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$78.1M | -159.0% |
| Capital Expenditures | $931K | +1035.4% |
| Investing Cash Flow | $57.9M | +139.2% |
| Financing Cash Flow | $1.6M | -99.3% |
| Free Cash Flow | -$79.1M | -161.3% |
| -38.8% |